Analysis

FDA Offers Road Map For Remote Trials, But Questions Linger

By Dan McKay · October 1, 2024, 2:08 PM EDT

New federal guidance may encourage drug and medical device companies to carry out more of their research in decentralized, remote clinical trials, allowing them to enroll a more diverse set of...

To view the full article, register now.